Features of cognitive impairment in patients with pharmacoresistant epilepsy and treatment optimization questions

Solihzoda, A, Majidova, Y, Maksudova, Kh, Солихзода, А, Маджидова, Ё, Максудова , Х, Солихзода, А, Маджидова, Ё, Максудова , Х

Nevrologiya · 2023-yil

Annotatsiya

Тhe article is devoted to the clinical and neurological features of pharmacoresistant epilepsy and the results of a clinical study of the use of the drug cortexin and pantocalcin in 50 patients with pharmacoresistant epilepsy.

Maqola ma’lumotlari
MualliflarSolihzoda, A, Majidova, Y, Maksudova, Kh, Солихзода, А, Маджидова, Ё, Максудова , Х, Солихзода, А, Маджидова, Ё, Максудова , Х
JurnalNevrologiya
NashriyotЎзбекистон неврологлар ассоциацияси, , Тошкент врачлар малакасини ошириш, институти
ISSN2010-5452
Nashr sanasi2023-04-20
Jild1
Son3
Betlar35-37
TilIngliz
Ilmiy sohaTibbiyot
Indeksga qo‘shilgan2026-08-27

Maqolaning asl sahifasi

Kalit so‘zlar

фармакорезистентная эпилепсия, кортексин, пантокальцин, антиконвульсивная терапия, нейропротекторы, фармакорезистент эпилепсия, кортексин, пантокальцин, антиконвульсив даво, нейропротекторлар, pharmacoresistant epilepsy, cortexin, pantocalcine anticonvulsant therapy, neuroprotector

Ilmiy soha

Tibbiyot

Iqtibos keltirish

APASolihzoda, A, Majidova, Y, Maksudova, Kh, Солихзода, А, Маджидова, Ё, Максудова , Х, Солихзода, А, Маджидова, Ё, & Максудова , Х (2023). Features of cognitive impairment in patients with pharmacoresistant epilepsy and treatment optimization questions. Nevrologiya, 1(3), 35-37. https://inlibrary.uz/index.php/nevrologiya/article/view/19344
GOST (OAK)Solihzoda, A va b. Features of cognitive impairment in patients with pharmacoresistant epilepsy and treatment optimization questions // Nevrologiya. – 2023. – T. 1, № 3. – P. 35-37.
MLASolihzoda, A, Majidova, Y, Maksudova, Kh, Солихзода, А, Маджидова, Ё, Максудова , Х, Солихзода, А, Маджидова, Ё, and Максудова , Х. “Features of cognitive impairment in patients with pharmacoresistant epilepsy and treatment optimization questions.” Nevrologiya, 1(3), 35-37, 2023. https://inlibrary.uz/index.php/nevrologiya/article/view/19344
ChicagoSolihzoda, A, Majidova, Y, Maksudova, Kh, Солихзода, А, Маджидова, Ё, Максудова , Х, Солихзода, А, Маджидова, Ё, and Максудова , Х. “Features of cognitive impairment in patients with pharmacoresistant epilepsy and treatment optimization questions.” Nevrologiya, 1(3), 35-37 (2023). https://inlibrary.uz/index.php/nevrologiya/article/view/19344
HarvardSolihzoda, A, Majidova, Y, Maksudova, Kh, Солихзода, А, Маджидова, Ё, Максудова , Х, Солихзода, А, Маджидова, Ё, and Максудова , Х (2023) ‘Features of cognitive impairment in patients with pharmacoresistant epilepsy and treatment optimization questions’, Nevrologiya, 1(3), 35-37. https://inlibrary.uz/index.php/nevrologiya/article/view/19344
BibTeX
@article{solihzodaa2023,
  title = {Features of cognitive impairment in patients with pharmacoresistant epilepsy and treatment optimization questions},
  author = {Solihzoda, A and Majidova, Y and Maksudova, Kh and Солихзода, А and Маджидова, Ё and Максудова , Х and Солихзода, А and Маджидова, Ё and Максудова , Х},
  journal = {Nevrologiya},
  year = {2023},
  volume = {1},
  number = {3},
  pages = {35-37},
  url = {https://inlibrary.uz/index.php/nevrologiya/article/view/19344}
}

Boshqa maqola uchun iqtibos tayyorlash

Nevrologiya jurnalidan boshqa maqolalar

Nevrologiya — barcha maqolalar · 2023-yil arxivi

Solihzoda, A — boshqa maqolalari

Tibbiyot sohasidagi boshqa maqolalar

Tibbiyot sohasidagi OAK jurnallari